Form 4 Filing for Knight Jeff E. - Crinetics Pharmaceuticals, Inc.

On April 8, 2026, Knight Jeff E., Chief Dev. & Operating Officer of Crinetics Pharmaceuticals, Inc., reported several transactions. These included the acquisition of 49,474 shares of Common Stock at $23.98 per share, 9,624 shares at $20.02, and 19,336 shares at $19.64. Concurrently, 85,163 shares of Common Stock were disposed of at an average price of $40.10 per share, executed under a Rule 10b5-1 trading plan. Additionally, stock options to acquire 49,474, 9,624, and 19,336 shares of Common Stock were exercised.